Cell Therapy: A New M&A Frontier
Middle Market Growth Conversations - Ein Podcast von Middle Market Growth Magazine - Freitags
![](https://is4-ssl.mzstatic.com/image/thumb/Podcasts125/v4/82/71/a5/8271a58e-d618-a93f-bf8b-908d2cb14692/mza_5126265760714722937.jpg/300x300bb-75.jpg)
Kategorien:
Cell and gene therapy technologies are ascendent, boosted by new developments in treatments for diseases like ovarian cancer and Parkinson’s disease, and by predictions of a meteoric rise in total market value in the next five years. Fabian Gerlinghaus, the co-founder and CEO of Cellares, a company that has developed a so-called “factory-in-a-box” for cell and gene therapy manufacturing, joins the podcast to share Cellares’ unique approach to developing successful cell therapies, the regulatory landscape and why investors should be watching this sector. *** The Middle Market Growth Conversations podcast is produced by the Association for Corporate Growth. To learn more about the organization and how to become a member, visit www.acg.org.